Cancer: Statins may significantly improve the overall survival rate of patients with triple-negative breast cancer

Previous studies have analyzed the correlation between statin therapy and breast cancer results, but different results have been obtained; recently, an article was published in the international journal Cancer entitled "Association of statin use with clinical outcomes in patients with triple-negative In the "breast cancer" research report, scientists from Baylor College of Medicine and other institutions found a significant correlation between cholesterol-lowering drugs called statins and the survival rate of triple-negative breast cancer patients

In this study, the researcher Professor Kevin Nead and others expanded their understanding of the relationship between currently used statins and triple-negative breast cancer, and for the first time investigated the relationship between statin intake and aggressive breast cancer subtypes.

Triple negative breast cancer is an aggressive type of breast cancer, which accounts for about 10%-20% of breast cancer diagnosis.

This study includes relevant data from 23,192 breast cancer patients over 66 years of age with grade I-III breast cancer.

Researcher Nead said that we all know that statins reduce the division of breast cancer cells and increase cell mortality.

Original source:

Malgorzata K.